MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.520
-0.050 (-3.18%)
Aug 1, 2025, 4:00 PM - Market closed
SolarWinds Market Cap
MAIA Biotechnology has a market cap or net worth of $46.07 million as of August 1, 2025. Its market cap has decreased by -42.36% in one year.
Market Cap
46.07M
Enterprise Value
35.20M
1-Year Change
-42.36%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has decreased from $51.10M to $46.07M, a decrease of -9.85%. That is a compound annual growth rate of -3.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 46.07M | -11.05% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |